WAYNE, Pa. (AP) — WAYNE, Pa. (AP) — Aclaris Therapeutics Inc. (ACRS) on Wednesday reported a loss of $7.6 million in its third quarter.

The Wayne, Pennsylvania-based company said it had a loss of 11 cents per share.

The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 8 cents per share.

The specialty pharmaceutical company posted revenue of $4.3 million in the period, also missing Street forecasts. Four analysts surveyed by Zacks expected $8.3 million.

The company's shares closed at $2.22. A year ago, they were trading at $5.48.

_____

This story was generated by Automated Insights (https://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACRS at https://www.zacks.com/ap/ACRS